Clinical& Demographic Profiles of patIents With unControllEd Asthma in Russia: Multi-center oBsErvational ReGistry Study (ICEBERG)
An Ambispective Observational Multicenter Registry of Patients With Uncontrolled Asthma in the Population of the Russian Federation
Sponsor: AstraZeneca
This observational or N/A phase trial investigates Uncontrolled Asthma and is currently actively recruiting participants. AstraZeneca leads this study, which shows 15 recorded versions since 2024 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
15 versions recorded-
Feb 2026 — Present [monthly]
Recruiting
-
Jan 2026 — Feb 2026 [monthly]
Recruiting
-
Nov 2025 — Jan 2026 [monthly]
Recruiting
-
Sep 2025 — Nov 2025 [monthly]
Recruiting
-
Jun 2025 — Sep 2025 [monthly]
Recruiting
▶ Show 10 earlier versions
-
May 2025 — Jun 2025 [monthly]
Recruiting
-
Apr 2025 — May 2025 [monthly]
Recruiting
-
Mar 2025 — Apr 2025 [monthly]
Recruiting
-
Feb 2025 — Mar 2025 [monthly]
Recruiting
-
Jan 2025 — Feb 2025 [monthly]
Recruiting
-
Dec 2024 — Jan 2025 [monthly]
Recruiting
-
Nov 2024 — Dec 2024 [monthly]
Recruiting
-
Oct 2024 — Nov 2024 [monthly]
Recruiting
-
Sep 2024 — Oct 2024 [monthly]
Recruiting
-
Aug 2024 — Sep 2024 [monthly]
Recruiting
First recorded
Jun 2024
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- AstraZeneca
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Gatchina, Russia , Ivanovo, Russia , Kazan', Russia , Krasnodar, Russia , Lipetsk, Russia , Makhachkala, Russia , Moscow, Russia , Nizhny Tagil, Russia , Perm, Russia , Pyatigorsk, Russia and 3 more locations